My interest got piqued recently in ASTM especially on their upcoming events related to CLI trial results. Very innovative approach to the treatment using their proprietary cell-processing technology to expand naturally occurring populations of stem and progenitor cells derived from the patient's bone marrow.
It could be next MNTA, if their upcoming "RESTORE-CLI Trial" results are successful.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.